Marcela Mazo, MD, talks with Marjolein Smidt, MD, PhD, about the results of the Phase III BOOG 2013-08 trial, which indicate that sentinel lymph node biopsy may be safely omitted in some patients with early-stage breast cancer.
Estimated Read Time:
1 minute
SABCS Snippets: Results of the BOOG 2013-08 Study
Share
Recent Posts
-
December 15, 2025
-
December 15, 2025
-
FDA session offers closer look at approval process for HR-positive metastatic breast cancer therapies
December 15, 2025 -
December 15, 2025
